Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPMT | P51580 | 4/20 | 0.58 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 5/20 | 0.50 |
| ▸ | CA2 | P00918 | 5/20 | 0.50 |
| ▸ | CA12 | O43570 | 4/20 | 0.50 |
| ▸ | CA6 | P23280 | 4/20 | 0.50 |
| ▸ | CA9 | Q16790 | 4/20 | 0.50 |
| ▸ | CA4 | P22748 | 3/20 | 0.50 |
| ▸ | CA7 | P43166 | 3/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.48 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.48 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29364242 | 1.00 | TPMT (0.58) | TPMTTSHRTP53CA1CA2 | |
| SCHEMBL205882 | 0.83 | TPMT (0.56) | TPMTTSHRTP53CA1CA2 | |
| SCHEMBL30574437 | 0.81 | CA12 (0.64) | TPMTTSHRTP53CA1CA2 | |
| SCHEMBL566608 | 0.81 | CA12 (0.64) | TPMTTSHRTP53CA1CA2 | |
| SCHEMBL30329647 | 0.81 | CA12 (0.64) | TPMTTSHRTP53CA1CA2 | |
| SCHEMBL7803073 | 0.81 | TPMT (0.54) | TPMTTSHRTP53CA1CA2 | |
| SCHEMBL351139 | 0.81 | CA12 (0.64) | TPMTTSHRTP53CA1CA2 | |
| SCHEMBL6645457 | 0.81 | TPMT (0.54) | TPMTTSHRTP53CA1CA2 | |
| SCHEMBL9080711 | 0.81 | KDM4E (0.52) | TPMTTSHRTP53CA1CA2 | |
| SCHEMBL17816183 | 0.79 | TPMT (0.48) | TPMTTSHRTP53CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110974816-B | Application of difunctional iodinated carboxylic acid as coxsackievirus inhibitor | 湖北工业大学 | 2023-05-16 | — | — | CN | claimed |
| CN-111053763-B | Application of bifunctional iodine-containing aromatic acid in resisting EV71 virus | 湖北工业大学 | 2021-04-02 | — | — | CN | claimed |
| CN-111116395-A | Multi-iodo aromatic acid compound and application thereof in resisting adenovirus 7 | 湖北工业大学 | 2020-05-08 | — | — | CN | claimed |
| CN-111053763-A | Application of bifunctional iodine-containing aromatic acid in resisting EV71 virus | 湖北工业大学 | 2020-04-24 | — | — | CN | claimed |
| CN-110974816-A | Application of bifunctional iodocarboxylic acid as coxsackie virus inhibitor | 湖北工业大学 | 2020-04-10 | — | — | CN | claimed |
| US-20260115330-A1 | RADIOPAQUE MULTI-ARM POLYMERS FOR MEDICAL APPLICATIONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260049178-A1 | CROSSLINKING AGENTS AND MEDICAL HYDROGELS FORMED THEREFROM | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-02-19 | — | — | US | disclosed |
| US-20260041799-A1 | HYDROLYSIS-RESISTANT HYDROGELS AND METHODS OF TREATMENT USING SAME | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-02-12 | — | — | US | disclosed |
| US-20260014282-A1 | METHODS OF FORMING RADIOPAQUE PEPTIDES FOR USE IN MEDICAL HYDROGELS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-01-15 | — | — | US | disclosed |
| US-20250249130-A1 | RADIOPAQUE POLYPEPTIDES FOR INJECTABLE COMPOSITIONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2025-08-07 | — | — | US | disclosed |
| US-20250059237-A1 | METHODS OF FORMING RADIOPAQUE PEPTIDES AND MEDICAL HYDROGELS FORMED THEREFROM | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2025-02-20 | — | — | US | disclosed |
| US-12146028-B2 | Iodo-functionalized polymers as mass spectrometry calibrants with a mass-defect offset | POLYMER FACTORY SWEDEN AB (SE) | 2024-11-19 | — | — | US | disclosed |
| US-9725457-B2 | 6-amido derivatives of 4, 5-a epoxymorphinans for the treatment of pain | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2017-08-08 | — | — | US | disclosed |
| EP-2630150-B1 | 6-AMIDO DERIVATIVES OF 4,5A-EPOXYMORPHINANS FOR TREATMENT OF PAIN | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2017-04-12 | — | — | EP | disclosed |
| US-20140255308-A1 | 6-AMIDO DERIVATIVES OF 4, 5-a EPOXYMORPHINANS FOR THE TREATMENT OF PAIN | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2014-09-11 | — | — | US | disclosed |
| US-20130289060-A1 | 6-AMIDO DERIVATIVES OF 4, 5-a EPOXYMORPHINANS FOR THE TREATMENT OF PAIN | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2013-10-31 | — | — | US | disclosed |
| EP-2630150-A2 | 6-AMIDO DERIVATIVES OF 4,5A-EPOXYMORPHINANS FOR TREATMENT OF PAIN | Memorial Sloan-Kettering Cancer Center (US) | 2013-08-28 | — | — | EP | disclosed |
| WO-2012054566-A2 | 6-AMIDO DERIVATIVES OF 4,5A-EPOXYMORPHINANS FOR TREATMENT OF PAIN | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2012-04-26 | — | — | WO | disclosed |
| US-7371866-B2 | Preparation of aromatic and heteroaromatic carboxylic acids by catalytic ozonolysis | DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO KG (AT) | 2008-05-13 | — | — | US | disclosed |
| US-20030216577-A1 | Preparation of aromatic and heteroaromatic carboxylic acids by catalytic ozonolysis | DSM FINE CHEMICALS AUSTRIA NFG GMBH & COKG (AT) | 2003-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250059237-A1 | METHODS OF FORMING RADIOPAQUE PEPTIDES AND MEDICAL HYDROGELS FORMED THEREFROM | HDGF, IAPP, QRFPR | TPMT 4779/4885TSHR 189/4885TP53 151/4885 |
| US-20130289060-A1 | 6-AMIDO DERIVATIVES OF 4, 5-a EPOXYMORPHINANS FOR THE TREATMENT OF PAIN | OPRL1, OPRM1, OPRD1 | TPMT 1853/4885TSHR 517/4885TP53 4683/4885 |
| US-20260115330-A1 | RADIOPAQUE MULTI-ARM POLYMERS FOR MEDICAL APPLICATIONS | KLK3, BRDT, BPHL | TPMT 4080/4885TSHR 689/4885TP53 19/4885 |
| US-20260049178-A1 | CROSSLINKING AGENTS AND MEDICAL HYDROGELS FORMED THEREFROM | NPPA, MACF1, IGF1R | TPMT 3130/4885TSHR 103/4885TP53 1399/4885 |
| US-20260014282-A1 | METHODS OF FORMING RADIOPAQUE PEPTIDES FOR USE IN MEDICAL HYDROGELS | IAPP, NPPA, ARG1 | TPMT 4779/4885TSHR 288/4885TP53 220/4885 |
| US-20140255308-A1 | 6-AMIDO DERIVATIVES OF 4, 5-a EPOXYMORPHINANS FOR THE TREATMENT OF PAIN | OPRL1, OPRM1, OPRD1 | TPMT 1853/4885TSHR 517/4885TP53 4683/4885 |
| US-20260041799-A1 | HYDROLYSIS-RESISTANT HYDROGELS AND METHODS OF TREATMENT USING SAME | PAM, CRYAA, COL1A1 | TPMT 3261/4885TSHR 3455/4885TP53 1394/4885 |
| US-20250249130-A1 | RADIOPAQUE POLYPEPTIDES FOR INJECTABLE COMPOSITIONS | IAPP, IGFBP6, NPPA | TPMT 4869/4885TSHR 468/4885TP53 80/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.